Your browser doesn't support javascript.
Health effects and known pathology associated with the use of E-cigarettes.
Esteban-Lopez, Maria; Perry, Marissa D; Garbinski, Luis D; Manevski, Marko; Andre, Mickensone; Ceyhan, Yasemin; Caobi, Allen; Paul, Patience; Lau, Lee Seng; Ramelow, Julian; Owens, Florida; Souchak, Joseph; Ales, Evan; El-Hage, Nazira.
  • Esteban-Lopez M; Departments of Human and Molecular Genetics, Florida International University, Miami, FL 33199, USA.
  • Perry MD; Immunology and Nano-medicine, Florida International University, Miami, FL 33199, USA.
  • Garbinski LD; Cell Biology and Pharmacology and Florida International University, Miami, FL 33199, USA.
  • Manevski M; Immunology and Nano-medicine, Florida International University, Miami, FL 33199, USA.
  • Andre M; Immunology and Nano-medicine, Florida International University, Miami, FL 33199, USA.
  • Ceyhan Y; Departments of Human and Molecular Genetics, Florida International University, Miami, FL 33199, USA.
  • Caobi A; Immunology and Nano-medicine, Florida International University, Miami, FL 33199, USA.
  • Paul P; Translational Glycobiology, Florida International University, Miami, FL 33199, USA.
  • Lau LS; Translational Glycobiology, Florida International University, Miami, FL 33199, USA.
  • Ramelow J; Herbert Wertheim College of Medicine, Biological Sciences in the College of Arts, Science and Education and the Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, USA.
  • Owens F; Immunology and Nano-medicine, Florida International University, Miami, FL 33199, USA.
  • Souchak J; Translational Glycobiology, Florida International University, Miami, FL 33199, USA.
  • Ales E; Translational Glycobiology, Florida International University, Miami, FL 33199, USA.
  • El-Hage N; Immunology and Nano-medicine, Florida International University, Miami, FL 33199, USA.
Toxicol Rep ; 9: 1357-1368, 2022.
Article in English | MEDLINE | ID: covidwho-1895464
ABSTRACT
In recent years, new nicotine delivery methods have emerged, and many users are choosing electronic cigarettes (e-cigarettes) over traditional tobacco cigarettes. E-cigarette use is very popular among adolescents, with more than 3.5 million currently using these products in the US. Despite the increased prevalence of e-cigarette use, there is limited knowledge regarding the health impact of e-cigarettes on the general population. Based on published findings by others, E-cigarette is associated with lung injury outbreak, which increased health and safety concerns related to consuming this product. Different components of e-cigarettes, including food-safe liquid solvents and flavorings, can cause health issues related to pneumonia, pulmonary injury, and bronchiolitis. In addition, e-cigarettes contain alarmingly high levels of carcinogens and toxicants that may have long-lasting effects on other organ systems, including the development of neurological manifestations, lung cancer, cardiovascular disorders, and tooth decay. Despite the well- documented potential for harm, e-cigarettes do not appear to increase susceptibility to SARS-CoV- 2 infection. Furthermore, some studies have found that e-cigarette users experience improvements in lung health and minimal adverse effects. Therefore, more studies are needed to provide a definitive conclusion on the long-term safety of e-cigarettes. The purpose of this review is to inform the readers about the possible health-risks associated with the use of e-cigarettes, especially among the group of young and young-adults, from a molecular biology point of view.
Keywords
AEC, airway epithelial cells; AM, alveolar macrophages; BAL, bronchial alveolar lavage; CC16, Clara cell protein 16; CM, cardiomyocyte; CNS, central nervous system; COPD, chronic obstructive pulmonary disease; CS, cigarette smoke; CSC, Cancer Stem Cell; CYP, cytochrome P450; E-cigarettes; E2F1, E2F transcription factor 1; EMT, epithelial-to-mesenchymal transition; ENDS, electronic nicotine delivery system; EVALI; EVALI, e-cigarette or vaping product use-associated lung injury; FDA, Food and Drug Administration; FOXO3, forkhead box O3; HNSCC, head and neck squamous cancer cells; HUVEC, human umbilical vein endothelial cells; Health risks; IL, interleukin; LDL, low-density lipoprotein; MCP-1, monocyte chemoattractant protein-1; MMP9, matrix metallopeptidase 9; MPP, Mycoplasma pneumoniae pneumonia; NET, neutrophil extracellular traps; NK, natural killer; NOX, NADPH oxidase; NQO-1, NAD(P)H quinone dehydrogenase 1; Nicotine; Nrf2, nuclear factor erythroid 2-related factor 2; OGG1/2, 8-oxoguanine glycosylase; OS, oxidative stress; Oct4,, Octamer-binding transcription factor 4; PAFR, platelet-activating factor receptor; PAHs, polycyclic aromatic hydrocarbons; PG, propylene glycol; ROS, reactive oxygen species; Sox2,, SRY (sex determining region Y)-box 2; THC, Tetrahydrocannabinol; TNF­α, tumor necrosis factor alpha; VAPI, vaping-associated pulmonary injury; VG, vegetable glycerin; Vaping; XPC, xeroderma pigmentosum complementation group C; Yap1, Yes associated protein 1; ZEB, zinc finger E-box binding homeobox; ZO-1, zonula occludens-1; e-cigarettes, electronic cigarettes; e-liquid, e-cigarette liquid; e-vapor, e-cigarette vapor; iPSC-EC, induced pluripotent stem cell-derived endothelial cells; pAMPK, phospho-AMP-activated protein kinase

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Toxicol Rep Year: 2022 Document Type: Article Affiliation country: J.toxrep.2022.06.006

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Toxicol Rep Year: 2022 Document Type: Article Affiliation country: J.toxrep.2022.06.006